Claritev Corporation (CTEV) Financial Ratios
7 years of historical data (2019–2025) · Healthcare · Medical - Healthcare Information Services
EV/EBITDA
10.37
-4% vs avg
5yr avg: 10.78
30Y Low10.8·High10.8
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
N/A
—
5yr avg: N/A
ROE
↓
N/A
—
5yr avg: -53.1%
30Y Low-184%·High4%
Debt/EBITDA
↑
9.39
↓-67% vs avg
5yr avg: 28.42
30Y Low6.2·High17.0
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
CTEV Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Claritev Corporation currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Market Cap | $502M | $703M | — | — | — | — | — | — |
| Enterprise Value | $5.1B | $5.3B | — | — | — | — | — | — |
| P/E Ratio → | -1.70 | — | — | — | — | — | — | — |
| P/S Ratio | 0.52 | 0.73 | — | — | — | — | — | — |
| P/B Ratio | — | — | — | — | — | — | — | — |
| P/FCF | — | — | — | — | — | — | — | — |
| P/OCF | 4.27 | 5.99 | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
CTEV EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Claritev Corporation's enterprise value stands at 10.4x EBITDA, roughly in line with its 5-year average of 10.8x. The Healthcare sector median is 14.2x, placing the stock at a 27% discount on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 5.51 | — | — | — | — | — | — |
| EV / EBITDA | 10.37 | 10.78 | — | — | — | — | — | — |
| EV / EBIT | 113.57 | 197.05 | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — |
CTEV Profitability
Margins and return-on-capital ratios measuring operating efficiency
Claritev Corporation earns an operating margin of 4.7%. Operating margins have compressed from 16.8% to 4.7% over the past 3 years, signaling potential cost pressures or competitive headwinds. ROIC of 0.7% represents below-average returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 27.6% | 27.6% | 74.3% | 75.5% | 81.1% | 84.3% | 66.0% | 84.8% |
| Operating Margin | 4.7% | 4.7% | -149.4% | 16.8% | -33.6% | 34.5% | -14.1% | 37.5% |
| Net Profit Margin | -29.4% | -29.4% | -176.9% | -9.5% | -53.1% | 9.1% | -55.5% | 1.0% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| ROE | — | — | -183.6% | -5.2% | -27.7% | 4.2% | -22.9% | 0.5% |
| ROA | -5.7% | -5.7% | -27.2% | -1.3% | -7.3% | 1.2% | -6.3% | 0.1% |
| ROIC | 0.7% | 0.7% | -19.3% | 2.0% | -4.1% | 4.1% | -1.4% | 3.7% |
| ROCE | 0.9% | 0.9% | -23.7% | 2.3% | -4.7% | 4.8% | -1.6% | 4.4% |
CTEV Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Claritev Corporation carries a Debt/EBITDA ratio of 9.4x, which is highly leveraged (192% above the sector average of 3.2x). Net debt stands at $4.6B ($4.6B total debt minus $17M cash). Interest coverage of just 0.1x is concerning — the company has limited headroom to absorb earnings volatility before struggling with debt service.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | 54.05 | 2.67 | 2.67 | 2.10 | 1.80 | 2.74 |
| Debt / EBITDA | 9.39 | 9.39 | — | 7.77 | 90.36 | 6.17 | 16.97 | 7.07 |
| Net Debt / Equity | — | — | 53.85 | 2.63 | 2.48 | 2.02 | 1.75 | 2.72 |
| Net Debt / EBITDA | 9.35 | 9.35 | — | 7.65 | 84.05 | 5.94 | 16.50 | 7.04 |
| Debt / FCF | — | — | — | 71.52 | 15.74 | 14.81 | 14.63 | 24.82 |
| Interest Coverage | 0.07 | 0.07 | -4.43 | 0.68 | -0.85 | 1.51 | -0.63 | 1.03 |
CTEV Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.86x is below 1.0, meaning current liabilities exceed current assets. The current ratio has declined from 1.16x to 0.86x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.86 | 0.86 | 0.82 | 1.16 | 2.54 | 2.25 | 1.86 | 1.35 |
| Quick Ratio | 0.86 | 0.86 | 0.82 | 1.16 | 2.54 | 2.25 | 1.86 | 1.35 |
| Cash Ratio | 0.06 | 0.06 | 0.08 | 0.43 | 1.90 | 1.31 | 1.13 | 0.25 |
| Asset Turnover | — | 0.20 | 0.18 | 0.14 | 0.15 | 0.14 | 0.11 | 0.12 |
| Inventory Turnover | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | 52.24 | 43.77 | 32.17 | 26.67 | 32.63 | 24.60 | 28.62 |
CTEV Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Claritev Corporation does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | — | — | — | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | — | — | — | — | — | — |
| Shares Outstanding | — | $16M | $16M | $16M | $16M | $16M | $12M | $28M |
Peer Comparison
Compare CTEV with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 CTEVYou | $502M | -1.7 | 10.4 | — | 27.6% | 4.7% | — | 0.7% | 9.4 |
 EHTH | $51M | -4.9 | 1.4 | — | 97.5% | 12.4% | 5.1% | 6.1% | 1.6 |
 HIMS | $8B | 69.5 | 55.1 | 105.3 | 73.8% | 4.5% | 25.2% | 8.6% | 7.9 |
 TDOC | $1B | -7.1 | 17.1 | 5.1 | 69.5% | -10.4% | -13.9% | -11.5% | 10.4 |
 EXLS | $4B | 16.8 | 11.6 | 13.6 | 38.4% | 15.0% | 27.2% | 20.4% | 1.1 |
 PGNY | $2B | 40.1 | 21.7 | 10.7 | 23.6% | 6.6% | 12.5% | 18.1% | 0.3 |
 UNH | $364B | 30.3 | 17.9 | 22.6 | 18.5% | 4.2% | 11.8% | 9.2% | 3.4 |
 CVS | $125B | 70.7 | 14.0 | 16.1 | 13.8% | 2.6% | 2.3% | 5.0% | 6.2 |
 CI | $74B | 12.6 | 8.3 | 8.8 | 9.5% | 3.3% | 14.3% | 10.4% | 2.7 |
 HUM | $43B | 36.7 | 22.9 | 115.5 | 14.5% | 1.1% | 7.0% | 4.1% | 5.7 |
 MCK | $90B | 19.6 | 13.2 | 15.8 | 3.6% | 1.6% | — | 254.1% | 1.2 |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.2% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 7 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
CTEV — Frequently Asked Questions
Quick answers to the most common questions about buying CTEV stock.
What is Claritev Corporation's P/E ratio?
Claritev Corporation's current P/E ratio is -1.7x. This places it at the 50th percentile of its historical range.
What is Claritev Corporation's EV/EBITDA?
Claritev Corporation's current EV/EBITDA is 10.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 10.8x.
Is CTEV stock overvalued?
Based on historical data, Claritev Corporation is trading at a P/E of -1.7x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Claritev Corporation's profit margins?
Claritev Corporation has 27.6% gross margin and 4.7% operating margin.
How much debt does Claritev Corporation have?
Claritev Corporation's Debt/EBITDA ratio is 9.4x, indicating high leverage. A ratio above 4x may signal elevated financial risk.